Ardea Outcomes
@ArdeaOutcomes
Followers
136
Following
215
Media
105
Statuses
330
Generating personalized evidence through Goal Attainment Scaling (GAS) in clinical development.
Halifax, Nova Scotia, Canada
Joined June 2011
We are excited and ready for #ISPOREurope! Stop by our booth #527 to chat with our team and CEO about #GoalAttainmentScaling and learn how we can assist your organization in implementing this #personalizedendpoint in #clinicaldevelopment. We look forward to seeing you there!
0
0
1
#ISPOR Europe! We are excited to connect with peers and industry leaders and engage in insightful discussions about #GoalAttainmentScaling (GAS) and clinical outcomes. Don't miss our podium presentation on Monday, the 18th, at 2:30 PM. #ISPOR #ISPOREU #Clinicaloucomes #endpoints
0
0
1
#ISOQOL Don't miss our upcoming workshop tomorrow in partnership with IQVIA at Salon 17 Darmstadt from 1:00–4:00 PM. Get to learn more about #GoalAttainmentScaling. Looking forward to seeing you there!
0
0
0
RT @RareRevolutionM: The “cutting-edge” approach of #GoalAttainmentScaling has the power to give the patient a voice in decision-making and….
0
1
0
Excited about the new #publication on #GoalAttainmentScaling (GAS) in #dementia care, co-authored by Dr. @Krockdoc, @ClaudiaACooper1, highlighting the NIDUS Family intervention's positive impact on achieving personalized goals. #NIDUSFamily #Dementia.
0
1
3
RT @ArdeaOutcomes: Last April, we launched our first Ardea Outcomes Monthly Edit. Our newsletter features the most recent #GoalAttainmentSc….
0
1
0
🚀 We’re excited to see the EU-US @CTAD Task Force highlight #GoalAttainmentScaling as a novel, personalized outcome measure in their recent publication! Thanks to the authors for advancing innovative approaches to #Alzheimer's research. 🧠📊 Read more:
link.springer.com
The Journal of Prevention of Alzheimer's Disease - Recent positive results of three phase III anti-amyloid monoclonal antibody trials are transforming the landscape of disease-modifying...
0
0
1
Last April, we launched our first Ardea Outcomes Monthly Edit. Our newsletter features the most recent #GoalAttainmentScaling (GAS) scientific updates and team news. Make sure to sign up for our GAS newsletter to get the latest news! ..#newsletters
0
1
1
Heading to #ISPORannual? Join us on May 6th for our poster presentation and meet our CEO, Chere Chapman! We would love to discuss everything #GoalAttainmentScaling (GAS)and how it can be utilized as a personalized endpoint. #ISPOR #Clinicaltrials #GoalAttainmentScale #endpoints
0
0
1
We look forward to #ISPORAnnual in Atlanta, GA. Join us for our poster presentation! Our team will present a review of Goal Attainment Scaling (GAS) implementation as a personalized clinical outcome assessment over the Last Decade. #conferences #ISPOR #goalattainmentscaling
0
0
1
New #Publication Alert🚨 📝 .We conducted a systematic review of studies that implemented #GoalAttainmentScaling (GAS) with caregiver input and examined variations in the implementation, analysis, and reporting of GAS in these studies. Access here:
0
1
3
RT @ExactisI: 🚨 New release of #WhatsWithRWE! We spoke with Chere Chapman, CEO of @ArdeaOutcomes, a Canadian CRO focusing on goal attainmen….
0
1
0
Excited to see this cutting-edge research from our Co-Founder & President @Krockdoc, @ClaudiaACooper1, and colleagues at @UCL outlining the novel use of #GAS to support independent living in #Alzheimer's disease in the UK. #personalizedendpoints
independent.co.uk
A new study examined the first-ever post-diagnostic support programme for people with the condition.
0
1
1
#InternationalWomensDay! Today we celebrate all women contributing to scientific research and impacting lives. As a women-led company, we're proud to have @ChereChapman at the helm and a 60% female workforce. #IWD2024 #inclusion #womeninstem
0
0
0
We're gearing up for @OrphanConf in April. Our #abstracts have been submitted, and we’re preparing our workshop with @trendcommunity on personalized endpoints in #PraderWilli Syndrome. Join us in Boston! #patientcenteredoutcomes #sociallistening #raredisease #partnership.
5
1
2
#Throwback to one example evaluating the utility of #GoalAttainmentScaling (GAS) as an outcome measure in Alzheimer's disease. We explored GAS’s sensitivity to change, allowing it to detect small but menaingfulchanges. #personalizedendpoints #COAs .
0
0
0
In our recent collaboration with the InchStone project, we explored clinical trial readiness in rare DEEs through the lens of patient-focused drug development guidelines and #personalizedendpoints. Read the full publication here: #PFDD #Raredisease #GAS.
neurology.org
Developmental and epileptic encephalopathies (DEE) are rare, often monogenic neurodevelopmental conditions. Most affected individuals have refractory seizures. All have multiple severe impairments...
0
0
0
Our collaboration with the @DEE_Pconnection and @FamilieSCN2A sought to describe what meaningful change means in individuals affected by severe SCN2A-related developmental and epileptic encephalopathy. #DEEs #raredisease #Goalattainmentscaling.
0
1
2
Watch our Research Manager, Gunes Sevinc, outline strategies to standardize the implementation of Goal Attainment Scaling as a personalized endpoint in clinical development. #webinars #PFDD #Goalattainmentscaling #personalizedendpoints.Watch full webinar:
1
3
3